Detailed answers about PHARMACEUTICAL BUSINESS CONFERENCE GROUP LIMITED, including incorporation, status, business activity, and accounts information.
When was PHARMACEUTICAL BUSINESS CONFERENCE GROUP LIMITED founded?
PHARMACEUTICAL BUSINESS CONFERENCE GROUP LIMITED was officially incorporated on 1 September 2022 and is registered under company number 14330344. Incorporation establishes the company as a legal entity registered at Companies House, allowing it to trade, enter contracts, and operate under UK company law.
What type of company is PHARMACEUTICAL BUSINESS CONFERENCE GROUP LIMITED?
Private Limited Company. This classification indicates the legal structure of the company, which determines the way it is governed, its liability, and regulatory obligations. A private limited company (Ltd) limits the personal liability of its shareholders.
What is the current status of PHARMACEUTICAL BUSINESS CONFERENCE GROUP LIMITED?
PHARMACEUTICAL BUSINESS CONFERENCE GROUP LIMITED's current status is Active. The company status indicates whether it is actively trading, dormant, or has been dissolved. Maintaining an active status is essential for legally conducting business, filing accounts, and maintaining credibility with partners and lenders.
What does PHARMACEUTICAL BUSINESS CONFERENCE GROUP LIMITED do?
PHARMACEUTICAL BUSINESS CONFERENCE GROUP LIMITED operates in the following sector: 82302 - Activities of conference organisers. This provides insight into the company's primary business activity and industry focus.
What is PHARMACEUTICAL BUSINESS CONFERENCE GROUP LIMITED's registered address?
The registered office address of PHARMACEUTICAL BUSINESS CONFERENCE GROUP LIMITED is VINE HOUSE, 234 TONBRIDGE ROAD, WATERINGBURY, UNITED KINGDOM, ME18 5NY. This is the official address filed with Companies House for legal and statutory correspondence.
Is PHARMACEUTICAL BUSINESS CONFERENCE GROUP LIMITED financially stable?
The most recent accounts for PHARMACEUTICAL BUSINESS CONFERENCE GROUP LIMITED were made up to 30 June 2025, filed as TOTAL EXEMPTION FULL. Next accounts are due by 31 March 2027.